Global Cell And Gene Therapy Cold Chain Logistics Market Research Report 2024

Buy Now
Share to
Facebook
Twitter
LinkedIn
WhatsApp
Base Year
2024
Forecast Period
2024-2029
Pages
136
Industry
Manufacturing & Industry
Regions
Global
Updated
December 2025

Report Overview


Global Cell and Gene Therapy Cold Chain Logistics Market Research Report 2024

This report provides a deep insight into the global Cell and Gene Therapy Cold Chain Logistics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cell and Gene Therapy Cold Chain Logistics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cell and Gene Therapy Cold Chain Logistics market in any manner.

Global Cell and Gene Therapy Cold Chain Logistics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company
AmerisourceBergen Corporation
Arvato Supply Chain Solutions SE
Be The Match BioTherapies
BioLife Solutions
Cardinal Health
Catalent
Cryoport
BioStor Sytems
Marken
Polar Express Transportation
Thermo Fisher Scientific
Yourway Biopharma Services Company

Market Segmentation (by Type)
Air Freight
Ground Transportation
Water Transport

Market Segmentation (by Application)
Biopharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others

Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Cell and Gene Therapy Cold Chain Logistics Market
• Overview of the regional outlook of the Cell and Gene Therapy Cold Chain Logistics Market:

Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell and Gene Therapy Cold Chain Logistics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Table of Contents

  • 1 Research Methodology and Statistical Scope
    • 1.1 Market Definition and Statistical Scope of Cell and Gene Therapy Cold Chain Logistics
    • 1.2 Key Market Segments
      • 1.2.1 Cell and Gene Therapy Cold Chain Logistics Segment by Type
      • 1.2.2 Cell and Gene Therapy Cold Chain Logistics Segment by Application
    • 1.3 Methodology & Sources of Information
      • 1.3.1 Research Methodology
      • 1.3.2 Research Process
      • 1.3.3 Market Breakdown and Data Triangulation
      • 1.3.4 Base Year
      • 1.3.5 Report Assumptions & Caveats
    • 1.4 Key Data of Global Auto Market
      • 1.4.1 Global Automobile Production by Country
      • 1.4.2 Global Automobile Production by Type
  • 2 Cell and Gene Therapy Cold Chain Logistics Market Overview
    • 2.1 Global Market Overview
      • 2.1.1 Global Cell and Gene Therapy Cold Chain Logistics Market Size (M USD) Estimates and Forecasts (2019-2030)
      • 2.1.2 Global Cell and Gene Therapy Cold Chain Logistics Sales Estimates and Forecasts (2019-2030)
    • 2.2 Market Segment Executive Summary
    • 2.3 Global Market Size by Region
  • 3 Cell and Gene Therapy Cold Chain Logistics Market Competitive Landscape
    • 3.1 Global Cell and Gene Therapy Cold Chain Logistics Sales by Manufacturers (2019-2024)
    • 3.2 Global Cell and Gene Therapy Cold Chain Logistics Revenue Market Share by Manufacturers (2019-2024)
    • 3.3 Cell and Gene Therapy Cold Chain Logistics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4 Global Cell and Gene Therapy Cold Chain Logistics Average Price by Manufacturers (2019-2024)
    • 3.5 Manufacturers Cell and Gene Therapy Cold Chain Logistics Sales Sites, Area Served, Product Type
    • 3.6 Cell and Gene Therapy Cold Chain Logistics Market Competitive Situation and Trends
      • 3.6.1 Cell and Gene Therapy Cold Chain Logistics Market Concentration Rate
      • 3.6.2 Global 5 and 10 Largest Cell and Gene Therapy Cold Chain Logistics Players Market Share by Revenue
      • 3.6.3 Mergers & Acquisitions, Expansion
  • 4 Cell and Gene Therapy Cold Chain Logistics Industry Chain Analysis
    • 4.1 Cell and Gene Therapy Cold Chain Logistics Industry Chain Analysis
    • 4.2 Market Overview of Key Raw Materials
    • 4.3 Midstream Market Analysis
    • 4.4 Downstream Customer Analysis
  • 5 The Development and Dynamics of Cell and Gene Therapy Cold Chain Logistics Market
    • 5.1 Key Development Trends
    • 5.2 Driving Factors
    • 5.3 Market Challenges
    • 5.4 Market Restraints
    • 5.5 Industry News
      • 5.5.1 New Product Developments
      • 5.5.2 Mergers & Acquisitions
      • 5.5.3 Expansions
      • 5.5.4 Collaboration/Supply Contracts
    • 5.6 Industry Policies
  • 6 Cell and Gene Therapy Cold Chain Logistics Market Segmentation by Type
    • 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
    • 6.2 Global Cell and Gene Therapy Cold Chain Logistics Sales Market Share by Type (2019-2024)
    • 6.3 Global Cell and Gene Therapy Cold Chain Logistics Market Size Market Share by Type (2019-2024)
    • 6.4 Global Cell and Gene Therapy Cold Chain Logistics Price by Type (2019-2024)
  • 7 Cell and Gene Therapy Cold Chain Logistics Market Segmentation by Application
    • 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
    • 7.2 Global Cell and Gene Therapy Cold Chain Logistics Market Sales by Application (2019-2024)
    • 7.3 Global Cell and Gene Therapy Cold Chain Logistics Market Size (M USD) by Application (2019-2024)
    • 7.4 Global Cell and Gene Therapy Cold Chain Logistics Sales Growth Rate by Application (2019-2024)
  • 8 Cell and Gene Therapy Cold Chain Logistics Market Segmentation by Region
    • 8.1 Global Cell and Gene Therapy Cold Chain Logistics Sales by Region
      • 8.1.1 Global Cell and Gene Therapy Cold Chain Logistics Sales by Region
      • 8.1.2 Global Cell and Gene Therapy Cold Chain Logistics Sales Market Share by Region
    • 8.2 North America
      • 8.2.1 North America Cell and Gene Therapy Cold Chain Logistics Sales by Country
      • 8.2.2 U.S.
      • 8.2.3 Canada
      • 8.2.4 Mexico
    • 8.3 Europe
      • 8.3.1 Europe Cell and Gene Therapy Cold Chain Logistics Sales by Country
      • 8.3.2 Germany
      • 8.3.3 France
      • 8.3.4 U.K.
      • 8.3.5 Italy
      • 8.3.6 Russia
    • 8.4 Asia Pacific
      • 8.4.1 Asia Pacific Cell and Gene Therapy Cold Chain Logistics Sales by Region
      • 8.4.2 China
      • 8.4.3 Japan
      • 8.4.4 South Korea
      • 8.4.5 India
      • 8.4.6 Southeast Asia
    • 8.5 South America
      • 8.5.1 South America Cell and Gene Therapy Cold Chain Logistics Sales by Country
      • 8.5.2 Brazil
      • 8.5.3 Argentina
      • 8.5.4 Columbia
    • 8.6 Middle East and Africa
      • 8.6.1 Middle East and Africa Cell and Gene Therapy Cold Chain Logistics Sales by Region
      • 8.6.2 Saudi Arabia
      • 8.6.3 UAE
      • 8.6.4 Egypt
      • 8.6.5 Nigeria
      • 8.6.6 South Africa
  • 9 Key Companies Profile
    • 9.1 AmerisourceBergen Corporation
      • 9.1.1 AmerisourceBergen Corporation Cell and Gene Therapy Cold Chain Logistics Basic Information
      • 9.1.2 AmerisourceBergen Corporation Cell and Gene Therapy Cold Chain Logistics Product Overview
      • 9.1.3 AmerisourceBergen Corporation Cell and Gene Therapy Cold Chain Logistics Product Market Performance
      • 9.1.4 AmerisourceBergen Corporation Business Overview
      • 9.1.5 AmerisourceBergen Corporation Cell and Gene Therapy Cold Chain Logistics SWOT Analysis
      • 9.1.6 AmerisourceBergen Corporation Recent Developments
    • 9.2 Arvato Supply Chain Solutions SE
      • 9.2.1 Arvato Supply Chain Solutions SE Cell and Gene Therapy Cold Chain Logistics Basic Information
      • 9.2.2 Arvato Supply Chain Solutions SE Cell and Gene Therapy Cold Chain Logistics Product Overview
      • 9.2.3 Arvato Supply Chain Solutions SE Cell and Gene Therapy Cold Chain Logistics Product Market Performance
      • 9.2.4 Arvato Supply Chain Solutions SE Business Overview
      • 9.2.5 Arvato Supply Chain Solutions SE Cell and Gene Therapy Cold Chain Logistics SWOT Analysis
      • 9.2.6 Arvato Supply Chain Solutions SE Recent Developments
    • 9.3 Be The Match BioTherapies
      • 9.3.1 Be The Match BioTherapies Cell and Gene Therapy Cold Chain Logistics Basic Information
      • 9.3.2 Be The Match BioTherapies Cell and Gene Therapy Cold Chain Logistics Product Overview
      • 9.3.3 Be The Match BioTherapies Cell and Gene Therapy Cold Chain Logistics Product Market Performance
      • 9.3.4 Be The Match BioTherapies Cell and Gene Therapy Cold Chain Logistics SWOT Analysis
      • 9.3.5 Be The Match BioTherapies Business Overview
      • 9.3.6 Be The Match BioTherapies Recent Developments
    • 9.4 BioLife Solutions
      • 9.4.1 BioLife Solutions Cell and Gene Therapy Cold Chain Logistics Basic Information
      • 9.4.2 BioLife Solutions Cell and Gene Therapy Cold Chain Logistics Product Overview
      • 9.4.3 BioLife Solutions Cell and Gene Therapy Cold Chain Logistics Product Market Performance
      • 9.4.4 BioLife Solutions Business Overview
      • 9.4.5 BioLife Solutions Recent Developments
    • 9.5 Cardinal Health
      • 9.5.1 Cardinal Health Cell and Gene Therapy Cold Chain Logistics Basic Information
      • 9.5.2 Cardinal Health Cell and Gene Therapy Cold Chain Logistics Product Overview
      • 9.5.3 Cardinal Health Cell and Gene Therapy Cold Chain Logistics Product Market Performance
      • 9.5.4 Cardinal Health Business Overview
      • 9.5.5 Cardinal Health Recent Developments
    • 9.6 Catalent
      • 9.6.1 Catalent Cell and Gene Therapy Cold Chain Logistics Basic Information
      • 9.6.2 Catalent Cell and Gene Therapy Cold Chain Logistics Product Overview
      • 9.6.3 Catalent Cell and Gene Therapy Cold Chain Logistics Product Market Performance
      • 9.6.4 Catalent Business Overview
      • 9.6.5 Catalent Recent Developments
    • 9.7 Cryoport
      • 9.7.1 Cryoport Cell and Gene Therapy Cold Chain Logistics Basic Information
      • 9.7.2 Cryoport Cell and Gene Therapy Cold Chain Logistics Product Overview
      • 9.7.3 Cryoport Cell and Gene Therapy Cold Chain Logistics Product Market Performance
      • 9.7.4 Cryoport Business Overview
      • 9.7.5 Cryoport Recent Developments
    • 9.8 BioStor Sytems
      • 9.8.1 BioStor Sytems Cell and Gene Therapy Cold Chain Logistics Basic Information
      • 9.8.2 BioStor Sytems Cell and Gene Therapy Cold Chain Logistics Product Overview
      • 9.8.3 BioStor Sytems Cell and Gene Therapy Cold Chain Logistics Product Market Performance
      • 9.8.4 BioStor Sytems Business Overview
      • 9.8.5 BioStor Sytems Recent Developments
    • 9.9 Marken
      • 9.9.1 Marken Cell and Gene Therapy Cold Chain Logistics Basic Information
      • 9.9.2 Marken Cell and Gene Therapy Cold Chain Logistics Product Overview
      • 9.9.3 Marken Cell and Gene Therapy Cold Chain Logistics Product Market Performance
      • 9.9.4 Marken Business Overview
      • 9.9.5 Marken Recent Developments
    • 9.10 Polar Express Transportation
      • 9.10.1 Polar Express Transportation Cell and Gene Therapy Cold Chain Logistics Basic Information
      • 9.10.2 Polar Express Transportation Cell and Gene Therapy Cold Chain Logistics Product Overview
      • 9.10.3 Polar Express Transportation Cell and Gene Therapy Cold Chain Logistics Product Market Performance
      • 9.10.4 Polar Express Transportation Business Overview
      • 9.10.5 Polar Express Transportation Recent Developments
    • 9.11 Thermo Fisher Scientific
      • 9.11.1 Thermo Fisher Scientific Cell and Gene Therapy Cold Chain Logistics Basic Information
      • 9.11.2 Thermo Fisher Scientific Cell and Gene Therapy Cold Chain Logistics Product Overview
      • 9.11.3 Thermo Fisher Scientific Cell and Gene Therapy Cold Chain Logistics Product Market Performance
      • 9.11.4 Thermo Fisher Scientific Business Overview
      • 9.11.5 Thermo Fisher Scientific Recent Developments
    • 9.12 Yourway Biopharma Services Company
      • 9.12.1 Yourway Biopharma Services Company Cell and Gene Therapy Cold Chain Logistics Basic Information
      • 9.12.2 Yourway Biopharma Services Company Cell and Gene Therapy Cold Chain Logistics Product Overview
      • 9.12.3 Yourway Biopharma Services Company Cell and Gene Therapy Cold Chain Logistics Product Market Performance
      • 9.12.4 Yourway Biopharma Services Company Business Overview
      • 9.12.5 Yourway Biopharma Services Company Recent Developments
  • 10 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Region
    • 10.1 Global Cell and Gene Therapy Cold Chain Logistics Market Size Forecast
    • 10.2 Global Cell and Gene Therapy Cold Chain Logistics Market Forecast by Region
      • 10.2.1 North America Market Size Forecast by Country
      • 10.2.2 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Forecast by Country
      • 10.2.3 Asia Pacific Cell and Gene Therapy Cold Chain Logistics Market Size Forecast by Region
      • 10.2.4 South America Cell and Gene Therapy Cold Chain Logistics Market Size Forecast by Country
      • 10.2.5 Middle East and Africa Forecasted Consumption of Cell and Gene Therapy Cold Chain Logistics by Country
  • 11 Forecast Market by Type and by Application (2025-2030)
    • 11.1 Global Cell and Gene Therapy Cold Chain Logistics Market Forecast by Type (2025-2030)
      • 11.1.1 Global Forecasted Sales of Cell and Gene Therapy Cold Chain Logistics by Type (2025-2030)
      • 11.1.2 Global Cell and Gene Therapy Cold Chain Logistics Market Size Forecast by Type (2025-2030)
      • 11.1.3 Global Forecasted Price of Cell and Gene Therapy Cold Chain Logistics by Type (2025-2030)
    • 11.2 Global Cell and Gene Therapy Cold Chain Logistics Market Forecast by Application (2025-2030)
      • 11.2.1 Global Cell and Gene Therapy Cold Chain Logistics Sales (K Units) Forecast by Application
      • 11.2.2 Global Cell and Gene Therapy Cold Chain Logistics Market Size (M USD) Forecast by Application (2025-2030)
  • 12 Conclusion and Key Findings

Frequently Asked Questions

JSB Market Research is a global provider of market research reports, industry insights, and business intelligence solutions. We help companies, analysts, and decision-makers gain a deeper understanding of global and regional markets.

Our reports deliver data-driven insights, market opportunities, competitive landscapes, and future forecasts. These help your business make informed decisions, enter new markets confidently, and stay ahead of industry trends.

Yes. We offer tailored research services designed to meet your specific market, product, or competitor analysis needs. Our experts work closely with clients to deliver precise, relevant, and actionable insights.

Browse the desired report, select your preferred license type, and complete payment through our secure checkout. For corporate purchases or invoice payments, you can contact our support team directly.

Yes. You can request sample pages or a report overview. This helps you understand the structure, methodology, and depth of analysis before purchasing.